By Benjamin Chiou
Date: Monday 23 Mar 2026
(Sharecast News) - Croda International sparked on Monday after Goldman Sachs double-upgraded the shares to 'buy' from 'sell' as it said the speciality chemicals firm's own market-recovery actions have delivered organic sales growth ahead of expectations.
GS noted that Croda has outperformed ingredients peers such as Givaudan, Symrise and DSM-Firmenich.
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news